The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The anti-diabetic drug metformin does not affect bone mass in vivo or fracture healing
Authors
Keywords
Bone architecture, Fracture healing, Histomorphometry, Metformin, Micro-CT
Journal
OSTEOPOROSIS INTERNATIONAL
Volume 24, Issue 10, Pages 2659-2670
Publisher
Springer Nature
Online
2013-05-03
DOI
10.1007/s00198-013-2371-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Complications of Ankle Fracture in Patients With Diabetes
- (2016) Saad B. Chaudhary et al. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
- Distinct effects of pioglitazone and metformin on circulating sclerostin and biochemical markers of bone turnover in men with type 2 diabetes mellitus
- (2012) A H van Lierop et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice
- (2012) Chun Wang et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Mice lacking AMP-activated protein kinase α1 catalytic subunit have increased bone remodelling and modified skeletal responses to hormonal challenges induced by ovariectomy and intermittent PTH treatment
- (2012) J Jeyabalan et al. JOURNAL OF ENDOCRINOLOGY
- Protective Effect of Metformin on Periapical Lesions in Rats by Decreasing the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin
- (2012) Lingshuang Liu et al. JOURNAL OF ENDODONTICS
- Bone, sweet bone—osteoporotic fractures in diabetes mellitus
- (2012) Christine Hamann et al. Nature Reviews Endocrinology
- Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function
- (2011) Christine Hamann et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 d
- (2011) J. L. C. Borges et al. DIABETES OBESITY & METABOLISM
- Metformin prevents anti-osteogenic in vivo and ex vivo effects of rosiglitazone in rats
- (2011) Claudia Sedlinsky et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- The effects of metformin and letrozole on endometrium and ovary in a rat model
- (2011) Gokalp Oner et al. GYNECOLOGICAL ENDOCRINOLOGY
- AICAR, a Small Chemical Molecule, Primes Osteogenic Differentiation of Adult Mesenchymal Stem Cells
- (2011) Wei Wu et al. INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS
- Loading-related Regulation of Transcription Factor EGR2/Krox-20 in Bone Cells Is ERK1/2 Protein-mediated and Prostaglandin, Wnt Signaling Pathway-, and Insulin-like Growth Factor-I Axis-dependent
- (2011) Gul Zaman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats
- (2011) Qi-Guang Mai et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- AMP-activated protein kinase pathway and bone metabolism
- (2011) J Jeyabalan et al. JOURNAL OF ENDOCRINOLOGY
- Metformin Treatment Has No Beneficial Effect in a Dose-Response Survival Study in the SOD1G93A Mouse Model of ALS and Is Harmful in Female Mice
- (2011) Hannah M. Kaneb et al. PLoS One
- Diabetes Medications Related to an Increased Risk of Falls and Fall-Related Morbidity in the Elderly
- (2010) Helen D Berlie et al. ANNALS OF PHARMACOTHERAPY
- AMP-activated protein kinase (AMPK) activation regulates in vitro bone formation and bone mass
- (2010) M. Shah et al. BONE
- Metformin induces osteoblast differentiation via orphan nuclear receptor SHP-mediated transactivation of Runx2
- (2010) Won Gu Jang et al. BONE
- Metformin improves cardiac function in rats via activation of AMP-activated protein kinase
- (2010) Xiao-Fang Wang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- The effect of diabetes mellitus on osseous healing
- (2010) M. Retzepi et al. CLINICAL ORAL IMPLANTS RESEARCH
- Comparative effects of telmisartan, sitagliptin and metformin alone or in combination on obesity, insulin resistance, and liver and pancreas remodelling in C57BL/6 mice fed on a very high-fat diet
- (2010) Vanessa Souza-Mello et al. CLINICAL SCIENCE
- Effect of the anti-diabetic drug metformin on bone mass in ovariectomized rats
- (2010) Ying Gao et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
- (2010) A. Michael Parfitt et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Effect of Metformin on Alveolar Bone in Ligature-Induced Periodontitis in Rats: A Pilot Study
- (2010) Eun Jung Bak et al. JOURNAL OF PERIODONTOLOGY
- Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis
- (2010) Beata Lecka-Czernik Current Osteoporosis Reports
- Vertebral fractures in males with type 2 diabetes treated with rosiglitazone
- (2009) Tatiana Mancini et al. BONE
- Effect of metformin on bone marrow progenitor cell differentiation: In vivo and in vitro studies
- (2009) M Silvina Molinuevo et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Osteoblast differentiation is functionally associated with decreased AMP kinase activity
- (2009) Takayuki Kasai et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Effect of Rosiglitazone, Metformin, and Glyburide on Bone Biomarkers in Patients with Type 2 Diabetes
- (2009) Bernard Zinman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metformin reverses the deleterious effects of high glucose on osteoblast function
- (2009) Donghu Zhen et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
- (2009) Philip D Home et al. LANCET
- Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression
- (2008) Ippei Kanazawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Molecular basis for affected cartilage formation and bone union in fracture healing of the streptozotocin-induced diabetic rat
- (2008) Akira Ogasawara et al. BONE
- Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis
- (2008) Y. K. Loke et al. CANADIAN MEDICAL ASSOCIATION JOURNAL
- Rosiglitazone-Associated Fractures in Type 2 Diabetes: An analysis from A Diabetes Outcome Progression Trial (ADOPT)
- (2008) S. E. Kahn et al. DIABETES CARE
- Strain-Specific Effects of Rosiglitazone on Bone Mass, Body Composition, and Serum Insulin-Like Growth Factor-I
- (2008) Cheryl L. Ackert-Bicknell et al. ENDOCRINOLOGY
- Diabetic Patients Have an Increased Risk of Vertebral Fractures Independent of BMD or Diabetic Complications
- (2008) Masahiro Yamamoto et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search